Both Chinese and foreign vaccines are showing serious side effects, and appointments for Hong Kong people are down 20%.

According to Hong Kong Ming Pao, 23,800 people received their first dose of the vaccine in Hong Kong on Sunday, a decrease of 2,500 from the previous day, while the number of appointments for the CoronaVac and BioNTech vaccines decreased by about 24% and 22% respectively.

It is reported that the Pfizer-BioNTech vaccine (Pfizer vaccine), which was developed by Pfizer and BioNTech, was renamed “Fubitai vaccine” after it was introduced to mainland China by China Renaissance Group.

Last Saturday, 26,300 people received the two vaccines, and 13 of them were sent to hospital with serious side effects, the report said. Among them, a 61-year-old man suffered a rise in blood pressure and rash after receiving the Fubatai vaccine, while another 70-year-old woman suffered paralysis in her right hand and both are still in hospital.

Another 70-year-old man developed facial swelling after receiving the Coxin vaccine, and a 17-year-old woman developed vasovagal syncope after receiving the Fupirtide vaccine. Other side effects include generalized convulsions, hyperventilation, palpitations and dizziness.

According to statistics, seven people have died in Hong Kong after receiving the Coxin vaccine. The most recent case occurred in the early morning hours of March 14. The 63-year-old man, who received the vaccine on the 9th, felt weak a few hours later and was in “critical condition” when he went to Queen Elizabeth Hospital on the 13th, and died in the early hours of the next day.

According to the first phase summary report on vaccine safety surveillance released by the Hong Kong Department of health, as of March 7, there were 71 reports of vaccine abnormalities in Hong Kong, of which the Coxin vaccine accounted for 69; and globally, as of March 8, at least 56 people had died after receiving the Coxin vaccine.

Despite this, the Hong Kong government announced last week (March 16) that it would expand the priority vaccination population by lowering the age of appointment from 60 to 30 or above, and expanding the vaccination group to include students aged 16 and above studying outside Hong Kong, as well as domestic helpers.